Scalpel Weekly News

Week of: January 08, 2018

IN THE NEWS


First Shock Wave Device to Treat Diabetic Foot Ulcers

On December 18, 2017, the FDA permitted Sanuwave, Inc., to market the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. Click title to continue reading...


 
MEDICAL ALERTS


Heart Catheter Placement Device Recall; May Cause Air Embolism

On January 2, 2018, the FDA alerted the public that the Agilis Steerable Introducer Sheath’s hemostatic valve, which prevents blood from flowing back through the valve, may fail due to an improper seal of the sheath hub. Improper seals can allow blood to leak through the hub, cause the cap to fall off during the procedure, or can create a difference in pressure that allows air into the circulatory system (air embolism). Click title to continue reading...



New Drug for Dangerously Low Blood Pressure in Shock Patients

On December 21, 2017, the FDA approved La Jolla Pharmaceutical Company’s Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. Click title to continue reading...



Children with Congenital Zika Virus Infection Face Serious Challenges

On December 14, 2017, the CDC published the first report to show severe impairments of children with congenital Zika virus infection become more evident over time. The report found that most children born with microcephaly – small head size for age – and evidence of congenital Zika virus infection face severe health and developmental challenges at ages 19 to 24 months. Click title to continue reading...


  CASE ALERTS


Negligence Not Presumed from Lack of Pain Treatment Success; Jury Instruction

A woman suffered from chronic pain. To treat the chronic pain, the woman had a spinal cord stimulator implant, a type of implantable neuromodulation device that is used to send electrical signals to select areas of the spinal cord for the treatment of certain pain conditions. In conjunction with the spinal cord stimulator, the woman had an implantable pulse generator, a battery-powered micro-electronic device implanted in the body, which delivers electrical stimulation to the nervous system. Click title to continue reading...



Hospital Vicariously Liable if Ostensible Agency Shown

A pregnant woman was referred to a prenatal care clinic operated by a hospital. The clinic was staffed by nurses and physicians who volunteered their time, including the obstetrician who would later deliver the woman’s child. Click title to continue reading...



Mild Traumatic Brain Injury Causes Permanent Partial Disability

A man participated in the man’s employer’s long-term disability benefits plan. The plan stated that an employee was “Disabled if, because of Injury or Sickness Click title to continue reading...


FEATURE


Complaint Against Drug Manufacturer: Personal Injury from Experimental Use

As a special feature for our Premium subscribers we have included this feature containing an illustrative complaint for personal injuries resulting from the manufacture of a drug used as experimental treatment. In this illustrative situation, the drug manufacturer promoted the drug for an experimental use, the prevention of miscarriages. Click title to continue reading...